| Date Filed | Type | Description |
| 07/24/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2020 |
4
| OAKES FRANK R. (Director) has filed a Form 4 on Edesa Biotech, Inc.|
Txns:
| Exercised (in-or-at-the-money) 609 options to buy
@ $4, valued at
$2.4k
|
|
| 10/14/2020 |
4
| OAKES FRANK R. (Director) has filed a Form 4 on Edesa Biotech, Inc.|
Txns:
| Granted 20,000 options to buy
@ $7.44, valued at
$148.8k
|
|
| 02/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2020 |
4
| OAKES FRANK R. (Director) has filed a Form 4 on Edesa Biotech, Inc.|
Txns:
| Granted 1,218 shares
@ $4.11, valued at
$5k
Granted 914 options to buy
@ $4.8, valued at
$4.4k
Granted 609 options to buy
@ $4, valued at
$2.4k
|
|
| 09/13/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2019 |
4
| OAKES FRANK R. (President & CEO) has filed a Form 4 on Stellar Biotechnologies, Inc.|
Txns:
| Sold 4,000 shares
@ $1.2501, valued at
$5k
|
|
| 10/12/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/14/2018 |
4
| OAKES FRANK R. (President & CEO) has filed a Form 4 on Stellar Biotechnologies, Inc.|
Txns:
| Granted 40,000 options to buy
@ $0.84, valued at
$33.6k
|
|
| 06/28/2017 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 06/28/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |